Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
RV001
Tag: RV001
Scientific publication supports RhoVac’s cancer treatment method
1 March, 2022
RhoVac gives guidance on new indications for RV001
30 November, 2021
BioStock Studio: RhoVac CEO comments on latest news flow
13 October, 2021
RhoVac brings in Stifel as transaction advisor for RV001
12 October, 2021
Positive results for RhoVac in 3-year follow-up of phase I/II-study
6 October, 2021
Completed recruitment in RhoVac’s phase IIb trial
21 September, 2021
Completion of the recruitment for RhoVac’s Phase IIb study expected in...
30 August, 2021
Rhovac’s phase II study passes safety review
12 July, 2021
First new US clinic initiated in RhoVac’s phase IIb study
11 March, 2021
BioStock Studio: RhoVac’s CEO comments on the year-end report
12 February, 2021